@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAQgpPFnqerVyeI2pn-u3A5tMiO_NJPNes82OQaHbltXg#> .
@prefix this: <http://purl.org/np/RAQgpPFnqerVyeI2pn-u3A5tMiO_NJPNes82OQaHbltXg> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  rdf:OBJECT rdfs:label "the importance of organ injury prevention in COVID-19" .
  
  rdf:OBJECT-POSITION rdfs:label "(54, 65)" .
  
  rdf:PREDICATE rdfs:label "highlighted" .
  
  rdf:PREDICATE-POSITION rdfs:label "66" .
  
  rdf:SUBJECT rdfs:label "The still-controversial efficacy of Dexamethasone and tocilizumab" .
  
  rdf:SUBJECT-POSITION rdfs:label "(54, 65)" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C1609165> ns1:highlight <https://uts.nlm.nih.gov/uts/umls/concept/C5203670>;
    rdfs:label "tocilizumab" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C5203670> rdfs:label "covid-19" .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" .
  
  sub:assertion prov:generatedAtTime "2023-06-01T14:23:54.651453"^^xsd:dateTime .
  
  rdf:Statement rdfs:label "The still-controversial efficacy of Dexamethasone and tocilizumab highlighted the importance of organ injury prevention in COVID-19." .
  
  rdfs:ABSTRACT-UID rdfs:label "fp4chn9a" .
  
  rdfs:TRIPLE-UID rdfs:label "fp4chn9a-TRIPLE-ABSTRACT-4" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "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";
    npx:hasSignature "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";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}